Neil Bodick
2018
In 2018, Neil Bodick earned a total compensation of $1.4M as Chief Scientific Officer and Co-Founder at Flexion Therapeutics, a 100% increase compared to previous year.
Compensation breakdown
| Bonus | $137,120 |
|---|---|
| Option Awards | $578,632 |
| Salary | $428,500 |
| Stock Awards | $223,100 |
| Other | $36,438 |
| Total | $1,403,790 |
Bodick received $578.6K in option awards, accounting for 41% of the total pay in 2018.
Bodick also received $137.1K in bonus, $428.5K in salary, $223.1K in stock awards and $36.4K in other compensation.
Rankings
In 2018, Neil Bodick's compensation ranked 7,492nd out of 14,244 executives tracked by ExecPay. In other words, Bodick earned more than 47.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,492 out of 14,244 | 47th |
Division Manufacturing | 2,910 out of 5,765 | 50th |
Major group Chemicals And Allied Products | 1,092 out of 2,128 | 49th |
Industry group Drugs | 923 out of 1,817 | 49th |
Industry Pharmaceutical Preparations | 725 out of 1,391 | 48th |
Source: SEC filing on April 26, 2019.
Bodick's colleagues
We found four more compensation records of executives who worked with Neil Bodick at Flexion Therapeutics in 2018.